MTNB gets FDA Orphan Drug Status for treatment of   Cryptococcal Meningitis. In the July the stock popped 23% going from 69c to 85c on fast track news for this drug.https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=703119...